相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
Pengcheng Luo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Alexis N. Simpkins et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Joseph P. Marino
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice
Komal Sodhi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases
John D. Imig et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The Soluble Epoxide Hydrolase Inhibitor AR9281 Decreases Blood Pressure, Ameliorates Renal Injury and Improves Vascular Function in Hypertension
John D. Imig et al.
PHARMACEUTICALS (2009)
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension
Marlina Manhiani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo
Atsuko Motoki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model
Arzu Ulu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells
Houli Jiang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia
Wenri Zhang et al.
STROKE (2008)
1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties
In-Hae Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain
Bora Inceoglu et al.
LIFE SCIENCES (2006)
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
John M. Seubert et al.
CIRCULATION RESEARCH (2006)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Distribution of soluble epoxide hydrolase and of cytochrome P4502C8, 2C9, and 2J2 in human tissues
AE Enayetallah et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
